HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianfranco Gennarini Selected Research

Neurodegenerative Diseases (Neurodegenerative Disease)

12/2022Overall Role of Contactins Expression in Neurodevelopmental Events and Contribution to Neurological Disorders.
1/2017The role of Gpi-anchored axonal glycoproteins in neural development and neurological disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Gianfranco Gennarini Research Topics

Disease

2Nervous System Diseases (Neurological Disorders)
12/2022 - 01/2017
2Friedreich Ataxia (Friedreich's Ataxia)
12/2022 - 09/2020
2Neurodegenerative Diseases (Neurodegenerative Disease)
12/2022 - 01/2017
2Alzheimer Disease (Alzheimer's Disease)
01/2017 - 01/2017
1Parkinson Disease (Parkinson's Disease)
01/2021
1Mental Disorders (Mental Disorder)
01/2021
1Schizophrenia (Dementia Praecox)
01/2021
1Neuroblastoma
01/2019
1Multiple Sclerosis
01/2017
1Neuroinflammatory Diseases
01/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
03/2011
1Fasciculation (Fasciculations)
02/2005

Drug/Important Bio-Agent (IBA)

2ContactinsIBA
12/2022 - 01/2017
2FrataxinIBA
12/2022 - 09/2020
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Mitochondrial Proteins (Mitochondrial Protein)IBA
09/2020
1PolyphenolsIBA
01/2019
1Proteins (Proteins, Gene)FDA Link
01/2017
1Glycoproteins (Glycoprotein)IBA
01/2017
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2017
1Contactin 1IBA
01/2017
1Contactin 2IBA
01/2017
1LigandsIBA
01/2017
1Amyloid beta-PeptidesIBA
01/2017
1Infliximab (Remicade)FDA Link
03/2011
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2011
1Cell Adhesion MoleculesIBA
02/2005